We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+13.02%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.44B
AUM Growth
+$120M
Cap. Flow
-$28.9M
Cap. Flow %
-2.01%
Top 10 Hldgs %
46.5%
Holding
136
New
5
Increased
13
Reduced
35
Closed
2

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.93M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$1.35M
3
INCY icon
Incyte
INCY
+$1.17M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$711K
5
INMD icon
InMode
INMD
+$457K

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.1M
2
AMZN icon
Amazon
AMZN
+$8.55M
3
META icon
Meta Platforms (Facebook)
META
+$4.71M
4
SEDG icon
SolarEdge
SEDG
+$2.34M
5
CVSA
Covista Inc
CVSA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 45.52%
2 Communication Services 15.06%
3 Healthcare 14.04%
4 Consumer Discretionary 11.21%
5 Financials 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JKHY icon
76
Jack Henry & Associates
JKHY
$11.4B
$2.2M 0.15%
12,786
– –
CNC icon
77
Centene
CNC
$30.5B
$2.16M 0.15%
27,560
-3,093
-10% -$239K
UTHR icon
78
United Therapeutics
UTHR
$26.1B
$2.14M 0.15%
9,296
– –
CTRA
79
DELISTED
Coterra Energy
CTRA
$2.13M 0.15%
76,541
– –
UNH icon
80
UnitedHealth
UNH
$382B
$2.06M 0.14%
4,169
-100
-2% -$50.8K
VRTX icon
81
Vertex Pharmaceuticals
VRTX
$123B
$2.03M 0.14%
4,859
-1,998
-29% -$845K
DHR icon
82
Danaher
DHR
$138B
$1.98M 0.14%
+7,920
New +$1.93M
SYK icon
83
Stryker
SYK
$135B
$1.96M 0.14%
5,482
– –
PRFT
84
DELISTED
Perficient Inc
PRFT
$1.92M 0.13%
34,148
– –
ZS icon
85
Zscaler
ZS
$24.9B
$1.84M 0.13%
9,568
– –
RVTY icon
86
Revvity
RVTY
$12.6B
$1.84M 0.13%
17,551
– –
FTNT icon
87
Fortinet
FTNT
$112B
$1.77M 0.12%
25,980
– –
HUM icon
88
Humana
HUM
$43.9B
$1.69M 0.12%
4,883
– –
JNJ icon
89
Johnson & Johnson
JNJ
$640B
$1.61M 0.11%
10,183
– –
JAZZ icon
90
Jazz Pharmaceuticals
JAZZ
$16.1B
$1.61M 0.11%
13,345
+5,808
+77% +$711K
PCTY icon
91
Paylocity
PCTY
$7.75B
$1.53M 0.11%
8,930
– –
KAI icon
92
Kadant
KAI
$3.58B
$1.53M 0.11%
4,668
– –
MDT icon
93
Medtronic
MDT
$112B
$1.45M 0.1%
16,662
-10,014
-38% -$855K
BIO icon
94
Bio-Rad Laboratories Class A
BIO
$8.76B
$1.42M 0.1%
+4,107
New +$1.35M
YOU icon
95
Clear Secure
YOU
$5.88B
$1.38M 0.1%
64,993
– –
BIIB icon
96
Biogen
BIIB
$30.9B
$1.33M 0.09%
6,190
– –
BBSI icon
97
Barrett Business Services
BBSI
$1.01B
$1.27M 0.09%
40,008
– –
IBM icon
98
IBM
IBM
$213B
$1.25M 0.09%
6,542
-47
-0.7% -$8.57K
INCY icon
99
Incyte
INCY
$25.8B
$1.11M 0.08%
+19,522
New +$1.17M
KFRC icon
100
Kforce
KFRC
$1.05B
$1.08M 0.07%
15,255
– –
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Oak Associates held 136 positions worth $1.44B, up 9.1% from $1.32B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oak Associates's Q1 2024 filing shows 5 new, 13 increased, 35 reduced and 2 closed positions. Its largest new stake was Danaher: 7,920 shares worth $1.98M. The largest sale was Alphabet (Google) Class C, an estimated $10.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 45% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q1 2024 buy was Danaher: 7,920 shares worth $1.98M.
  • Oak Associates added most to Jazz Pharmaceuticals in Q1 2024, an estimated $711K increase.
  • Oak Associates's biggest Q1 2024 reduction was Alphabet (Google) Class C, cutting an estimated $10.1M.
  • Oak Associates fully exited SolarEdge in Q1 2024, selling an estimated $2.34M.
  • Oak Associates's ten largest holdings make up 47% of its $1.44B portfolio in Q1 2024.
  • Oak Associates opened 5 new positions and closed 2 in Q1 2024.
  • Oak Associates's portfolio value rose 9.1% quarter-over-quarter to $1.44B.

Based on Oak Associates's 13F filing for Q1 2024, filed 10 May 2024.